EDGAR Filing Documents for 0001415889-12-000664

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001415889-12-000664

Filing Date

2012-05-10

Accepted

2012-05-10 16:21:17

Documents

Period of Report

2012-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	echo10q-mar312012.htm	10-Q	698653
2	OPINION OF MORGAN LEWIS & BOCKIUS LLP	ex5-1.htm	EX-5.1	9966
3	AT MARKET ISSUANCE SALES AGREEMENT WITH MLV & CO. DATED MAY 9, 2012.	ex10-1.htm	EX-10.1	256910
4	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE	ex31-1.htm	EX-31.1	12582
5	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE	ex31-2.htm	EX-31.2	12576
6	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-1.htm	EX-32.1	5017
7	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-2.htm	EX-32.2	5053
8		morganlewis.jpg	GRAPHIC	13245
	Complete submission text file	0001415889-12-000664.txt		2545814

Data Files

Seq	Document	Type	Size
9	ecte-20120331.xml	EX-101.INS	235488
10	ecte-20120331.xsd	EX-101.SCH	15925
11	ecte-20120331_cal.xml	EX-101.CAL	38969
12	ecte-20120331_def.xml	EX-101.DEF	7263
13	ecte-20120331_lab.xml	EX-101.LAB	121149
14	ecte-20120331_pre.xml	EX-101.PRE	75335

Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103

Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)